Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Fee Klupp - , Heidelberg University  (Author)
  • Johannes Diers - , Heidelberg University  (Author)
  • Christoph Kahlert - , Department of Internal Medicine III, Division General Medicine, Department of Visceral, Thoracic and Vascular Surgery, Heidelberg University  (Author)
  • Lena Neumann - , Heidelberg University  (Author)
  • Niels Halama - , Heidelberg University  (Author)
  • Clemens Franz - , Heidelberg University  (Author)
  • Thomas Schmidt - , Heidelberg University  (Author)
  • Felix Lasitschka - , Heidelberg University , German Cancer Research Center (DKFZ) (Author)
  • Arne Warth - , Heidelberg University  (Author)
  • Juergen Weitz - , Department of Visceral, Thoracic and Vascular Surgery, TUD Dresden University of Technology (Author)
  • Moritz Koch - , TUD Dresden University of Technology, Department of Visceral, Thoracic and Vascular Surgery (Author)
  • Martin Schneider - , Heidelberg University  (Author)
  • Alexis Ulrich - , Heidelberg University  (Author)

Abstract

Background: Signal transducer and activator of transcription proteins (STATs) are crucial regulators of cell growth and differentiation; however, their specific prognostic impact in human colon cancer has only been studied to limited extent. We aimed to assess the prognostic significance of specific STAT expression patterns in colon carcinoma. Methods: Protein expression patterns of activated STAT1, STAT3, STAT4, and STAT5 in human colon carcinoma tissue and corresponding healthy mucosa (n = 104) were assessed using multiplex bead-based immunoassay technologies. Expression patterns were correlated with clinical and survival data. Immunohistochemistry was performed to assess spatial expression of STAT3 and STAT5. Results: STAT3 was underexpressed whereas STAT4 and STAT5 were overexpressed in colon carcinoma tissue. Primary tumors from patients with distant metastases (M1) displayed significantly increased expression of STAT1 and STAT3 but decreased expression of STAT4 and STAT5. Increased tumor expression of STAT1 or STAT3 was associated with impaired patient survival, whereas increased expression of STAT4 or STAT5 correlated with improved survival. Multivariate analysis identified an increased STAT3/STAT5 expressional ratio as an adverse prognostic marker in colon cancer patients. Conclusions: The tumor progression-associated transcription factors STAT3, STAT4, and STAT5 are differently expressed in colon carcinoma tissue and colon mucosa. Moreover, the STAT3/STAT5 expression ratio is an independent prognostic marker in colon cancer patients.

Details

Original languageEnglish
Pages (from-to)1548-1555
Number of pages8
JournalAnnals of surgical oncology
Volume22
Publication statusPublished - 1 Dec 2015
Peer-reviewedYes

External IDs

PubMed 25773877

Keywords

Sustainable Development Goals

ASJC Scopus subject areas